D
GH Research PLC GHRS
$10.99 -$0.19-1.70% NASDAQ
Recommendation
Prev Close
$11.18
Volume
1,242
Avg Vol (90D)
395,148
Market Cap
$693.47M
Dividend & Yield
--
52-Week Range
$6.00 - $20.50
P/E (TTM)
--
EPS (TTM)
-$0.7488
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
GH Research (GHRS, $11.18) RSI Indicator left the overbought zone on May 05, 2025
5/6/2025 - Tickeron - Technical Analysis
What Makes GH Research (GHRS) a New Buy Stock
5/5/2025 - Zacks Investment Research
GH Research (GHRS, $11.39) RSI Indicator left the overbought zone on May 02, 2025
5/3/2025 - Tickeron - Stocks
GH Research (GHRS, $10.77) price may drop as it broke higher Bollinger Band on May 01, 2025
5/2/2025 - Tickeron - Technical Analysis
GH Research (GHRS, $10.77) price moved above its 50-day Moving Average on May 01, 2025
5/2/2025 - Tickeron - Technical Analysis
GH Research (GHRS) Shares Cross Above 200 DMA
5/1/2025 - Market News Video
GH Research (GHRS, $9.54) entered Uptrend as Momentum indicator ascends above 0 level on Apr 30, 2025
5/1/2025 - Tickeron - Stocks
GH Research (GHRS, $9) entered Downtrend as Momentum indicator drops below 0 level on Apr 29, 2025
4/30/2025 - Tickeron - Stocks
Lynx1 Capital Management LP Buys 663,100 Shares of GH Research PLC (NASDAQ:GHRS)
4/29/2025 - MarketBeat
GH Research (GHRS) to Release Quarterly Earnings on Friday
4/27/2025 - MarketBeat
GH Research (GHRS, $9.5) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 23, 2025
4/24/2025 - Tickeron - Technical Analysis
GH Research (GHRS, $9.41) entered Uptrend as Momentum indicator ascends above 0 level on Apr 22, 2025
4/23/2025 - Tickeron - Stocks
GH Research (GHRS, $9) RSI Indicator left the oversold zone on April 11, 2025
4/12/2025 - Tickeron - Technical Analysis
Beckley Psytech's investors want to put more money into the psychedelics company at a $200 million valuation
4/9/2025 - Insider
GH Research (GHRS, $9.32) Aroon Indicator entered an Uptrend on April 07, 2025.
4/8/2025 - Tickeron - Stocks
GH Research (GHRS, $9.32) RSI Indicator left the oversold zone on April 07, 2025
4/8/2025 - Tickeron - Stocks
GH Research (GHRS, $10.09) Aroon Indicator entered an Uptrend on April 04, 2025.
4/5/2025 - Tickeron - Technical Analysis
GH Research (NASDAQ:GHRS) Sees Large Volume Increase - Should You Buy?
4/4/2025 - MarketBeat
GH Research (GHRS, $9.86) Aroon Indicator entered an Uptrend on April 03, 2025.
4/4/2025 - Tickeron - Stocks
GHRS Crosses Below Key Moving Average Level
4/3/2025 - Market News Video
GH Research (GHRS, $10.4) entered Downtrend as Momentum indicator drops below 0 level on Apr 02, 2025
4/3/2025 - Tickeron - Stocks
GH Research (GHRS, $10.4) Aroon Indicator entered an Uptrend on April 02, 2025.
4/3/2025 - Tickeron - Stocks
GH Research (NASDAQ:GHRS) Sees Large Volume Increase - Still a Buy?
4/2/2025 - Ticker Report
GH Research PLC (NASDAQ:GHRS) Given Consensus Rating of "Buy" by Brokerages
4/1/2025 - Ticker Report
GH Research (NASDAQ:GHRS) Stock Price Down 7.4% - Here's What Happened
3/29/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$49.99M
EBIT (TTM)
-$50.25M
Net Income (TTM)
-$38.96M
Balance Sheet
Total Assets (Q)
$188.27M
Total Debt (Q)
$624.00K
Total Liabilities (Q)
$9.32M
Book Value Per Share (Q)
$3.44
Cash Flow
Cash from Operations (TTM)
-$42.29M
Cash from Investing (TTM)
$65.14M
Cash from Financing (TTM)
-$304.00K
Net Change in Cash (TTM)
$22.37M
Filings
Filing Date
Thursday, February 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Loading...
Beta
1.08
7-Day Total Return
15.32%
30-Day Total Return
-14.67%
60-Day Total Return
-20.79%
90-Day Total Return
57.00%
Year to Date Total Return
38.94%
1-Year Total Return
-5.99%
2-Year Total Return
23.34%
3-Year Total Return
-8.42%
5-Year Total Return
--
52-week Low
Oct 07, 2024 - $6.00
52-week High
Feb 03, 2025 - $20.50
Valuation
Market Cap
$693.47M - Small Cap
Enterprise Value
$511.47M
Price/Sales (TTM)
--
Price/Book (Q)
3.25
Dividends and Shares
Shares Outstanding
52.03M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.ghres.com
Phone Number
353 1 437 8334
Address
Joshua Dawson House
Dublin, D02 RY95
Country
Ireland
Year Founded
2018
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
GH Research PLC, together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States. Its lead product candidate is... more
NASDAQ 05/06/2025 9:35AM Eastern Quotes delayed